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ABSTRACT
Translation initiation in eukaryotes is mediated
by assembly of the eIF4F complex over the m
7GTP
cap structure at the 5’-end of mRNAs. This requires
an interaction between eIF4E and eIF4G, two
eIF4F subunits. The Leishmania orthologs of eIF4E
are structurally diverged from their higher eukaryote
counterparts, since they have evolved to bind
the unique trypanosomatid cap-4 structure. Here,
we characterize a key eIF4G candidate from
Leishmania parasites (LeishIF4G-3) that contains a
conserved MIF4G domain. LeishIF4G-3 was found to
coelute with the parasite eIF4F subunits from an
m
7GTP-Sepharose column and to bind directly to
LeishIF4E. In higher eukaryotes the eIF4E-eIF4G
interaction is based on a conserved peptide signa-
ture [Y(X4)Lr], where X is any amino acid and ( is a
hydrophobic residue. A parallel eIF4E-binding pep-
tide was identified in LeishIF4G-3 (20-YPGFSLDE-
27). However, the binding motif varies extensively:
in addition to Y20 and L25, binding strictly requires
the presence of F23, whereas the hydrophobic
amino acid (() is dispensable. The LeishIF4E–
LeishIF4G-3 interaction was also confirmed by
nuclear magnetic resonance (NMR) studies. In view
of these diversities, the characterization of the par-
asite eIF4E–eIF4G interaction may not only serve as
a novel target for inhibiting Leishmaniasis but also
provide important insight for future drug discovery.
INTRODUCTION
Leishmaniasis is caused by trypanosomatid parasites that
cycle between invertebrate vectors and vertebrate hosts,
transforming between the promastigote and amastigote
life forms, respectively. Environmental conditions, such
as temperature and pH switches, were shown to induce
a stage-speciﬁc pattern of gene expression (1,2), which
in some species is suﬃcient to produce the axenic form
(amastigotes) observed in mammalian cells (3,4). Trypa-
nosomatids are ancient eukaryotes that diverged early in
evolution and therefore display a variety of unique molec-
ular features. Transcription of protein-coding genes is
polycistronic and the resulting pre-mRNAs are processed
by trans-splicing and polyadenylation (5,6). During trans-
splicing, a capped 39-nt exon of the spliced leader RNA
is joined to the 50-end of all transcripts. The 50-cap
of trypanosomatids consists of a highly modiﬁed
structure, which in addition to the m
7GTP cap found
at the 50-end of most eukaryotic mRNAs, contains
20-O-methylations on the ribose moieties of the ﬁrst four
transcribed nucleotides and unusual base-methylations
on the ﬁrst adenine and fourth uridine (m
7Gpppm3
6,6,20
Apm
20
Apm
20
Cpm2
3,20
U); this structure is thus denoted
cap-4 (7).
Cap-dependent translation is a common mechanism in
higher eukaryotes, which requires several factors. The cap-
binding complex, eIF4F, consists of three subunits, with
eIF4G serving as a scaﬀold protein for the whole complex
(8,9). eIF4G holds the cap-binding protein, eIF4E, and
the ATP-dependent RNA helicase, eIF4A. eIF4G also
associates with eIF3 (10,11), a multisubunit factor that
bridges the cap-binding complex and the small ribosomal
subunit, as well as with the poly(A)-binding protein
(PABP), which is found on the 30-end of most eukaryotic
mRNAs. These latter interactions allow the mRNA
circularization, which is assumed to stimulate translation
initiation (12,13). Assembly of the translation initiation
complex on the 50-mRNA cap structure (m
7GTP) is
rate-limiting and is therefore subject to strict regulation
(9,14).
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domains that are deﬁned by viral protease cleavage pat-
terns (10). The N-terminal segment includes eIF4E and
PABP binding sites (15,16). This domain is initially
unfolded, and partially folds upon binding to eIF4E in
the human complex (17). In yeast it folds to a larger
extent wrapping around eIF4E’s N-terminus (18). The
middle domain of eIF4G (MIF4G) is critical for assembly
of the translation machinery, since it harbors the binding
site for eIF3 and eIF4A (19,20). The MIF4G contains a
single HEAT domain, whereas the human C-terminus of
eIF4G contains two additional HEAT domains, which
include the binding site for Mnk1, a kinase that phosphor-
ylates eIF4E, and a second binding site for eIF4A (21).
The large subunit of the nuclear cap-binding complex,
CBP80, shares a common origin and domain structure
with the eIF4G (22). Other eIF4G isoforms include the
MIF4G domain but lack the N-terminal domain, such
as the human 97kDa protein DAP5 (23) or the 130kDa
splice-variant of the Caenorhabditis elegans eIF4G. They
were shown to participate in cap-independent translation
of transcripts encoding pro-apoptotic genes under stress
conditions (24). DAP5 is also necessary for maintaining
cell survival during mitosis by promoting cap-independent
translation of at least two prosurvival proteins represented
by Bcl2 and CDK1 (25).
The eIF4E–eIF4G interaction is a key target for trans-
lation control (26). This interaction relies on a short
sequence of about 15 amino acids in the N-terminus of
eIF4G, which contains a conserved motif Y(X4)L, where
X is any amino acid and  is a hydrophobic residue
(17,27,28). This motif forms a short helical structure that
binds conserved amino acids on the dorsal side of eIF4E
(17). Several other proteins, such as the eIF4E-binding
proteins (4E-BPs), contain this consensus sequence and
thus compete with eIF4G for binding to eIF4E, depending
upon its phosphorylation state. This regulates translation
by aﬀecting the 48S preinitiation complex formation (29).
Cap-binding proteins in trypanosomatids are expected
to have gone through structural adaptations that enable
them to interact with the unusual cap-4 structure. The
biochemical and cellular features of four eIF4E isoforms
in Leishmania major which were denoted LeishIF4E-1
through LeishIF4E-4, have been previously described
(30–32). None of these isoforms could functionally com-
plement a yeast eIF4E knockout strain, strongly support-
ing that they have a structurally diverged eIF4E/eIF4G
interface. Furthermore, since there is yet no in vitro sys-
tem for translation initiation for any of the trypanosoma-
tids, the speciﬁc role of the diﬀerent candidates was
evaluated indirectly by biochemical and biophysical
assays. Fluorescence titration assays showed that
LeishIF4E-1 and LeishIF4E-4 bind m
7GTP and cap-4
comparably well whereas LeishIF4E-2 binds mainly to
the cap-4. LeishIF4E-3 was found to bind mainly to
m
7GTP, excluding its involvement in translation of cap-
4 protected mRNAs (31). A bioinformatics search for
eIF4G revealed ﬁve isoforms that contain the HEAT
repeats of the MIF4G (32). Here we describe
LeishIF4G-3, the most probable candidate for functioning
as the Leishmania eIF4G, based on its ability to interact
with the LeishIF4Es. Using yeast two-hybrid, site-directed
mutagenesis and nuclear magnetic resonance (NMR)
spectroscopy techniques, we further characterize the con-
sensus peptide of LeishIF4G-3 (20-YPGFSLDE-27) that
is responsible for this interaction and highlight variations
between the Leishmania cap-binding complex and its
counterpart from higher eukaryotic hosts.
MATERIALS AND METHODS
Organisms
Leishmania major (Friedlin strain) were cultured in
Schneider’s medium supplemented with 10% fetal calf
serum (FCS), 4mM L-glutamine and 25mg/ml
gentamycin.
Affinity purification of the LeishIF4F complex over
m
7GTP-Sepharose
Leishmania major promastigotes (5 10
8–1 10
9) were
harvested, washed twice with PBS, and once with
Column Buﬀer [CB: 20mM HEPES pH 7.6, 2mM
EDTA, 1mM DTT, 50mM NaCl, 2mM iododoacetamide
and 1  protease Inhibitor cocktail (Sigma)]. The cells were
resuspended in CB, incubated for 5min on ice and lyzed
by sonication, which was followed by centrifugation at
15000g for 20min at 48C. The cellular extracts were
loaded on an m
7GTP-Sepharose column (Amersham) pre-
viously equilibrated with CB. The column was washed
with CB containing 100mM GTP. The proteins were
eluted with CB containing 500mM NaCl or with CB
buﬀer containing 200mMm
7GTP, concentrated by
Tri-chloroacetic acid (TCA) precipitation and separated
over a sodium dodecyl sulfate (SDS)–polyacrylamide gel
electrophoresis (SDS–PAGE, 15%). Protein bands were
identiﬁed by nano-liquid chromatography electrospray
ionization tandem mass spectrometry (nano-LC-ESI-MS/
MS) at the biological mass spectrometry facility of the
Weizmann Institute. The diﬀerent elution protocols
yielded the same LeishIF4F subunits in the eluates.
The open reading frame (ORF) of LeishIF4G-3 was
ampliﬁed by PCR using L. major genomic DNA as tem-
plate. For details on the primers see Supplementary Data,
Table 1. The ampliﬁed sequences were cloned into pGST
or pHis expression vectors and the plasmids were used to
transform Escherichia coli BL21 cells. Antibodies were
raised against recombinant proteins excised from gels in
New Zealand rabbits.
Polysome analysis over sucrose gradients
Leishmania major, which were grown at 268C and incu-
bated overnight at 358C, were used for polysomal analysis
over sucrose gradients (10–40%) as formerly described
(31). Fractions were collected from the top of the gradi-
ents and their O.D260nm was measured. Proteins were
recovered by TCA precipitation and separated by SDS–
PAGE (15%) followed by immunoblotting using antibo-
dies against the diﬀerent translation initiation factors, as
well as with antibodies against rpS6, marking the small
ribosomal subunit.
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The GST-LeishIF4G-3 fusion protein or GST alone as
control and LeishIF4Es were expressed in E. coli BL21
cells. Cells expressing each of these proteins were har-
vested and lyzed by sonication in Binding Buﬀer
(BB: 20mM MOPS pH 7.2, 50mM KCl, 250mM NaCl,
7mM b-Mercaptoethanol, 2mM MgCl2). GST-
LeishIF4G-3 or GST alone was immobilized on
Glutathione-Agarose beads (Sigma) previously equili-
brated with BB. The beads were then washed with
BB containing 0.1% Triton X-100 and incubated with
supernatants of lyzed bacteria containing expressed
LeishIF4Es. After extensive washing with BB containing
0.1% Triton X-100, the proteins were denatured with
Laemmli’s SDS–PAGE sample buﬀer, separated by
SDS–PAGE (15%) and subjected to western blot analysis
with appropriate antibodies.
In vivo pull-down analysis of LeishIF4F components
The coding regions of LeishIF4E-1 and LeishIF4E-4
lacking stop codons were ampliﬁed and cloned into
pSNSAP1 (33), generating vectors pTAP-LeishIF4E-1 or
LeishIF4E-4. The coding region of LeishIF4G-3 was
ampliﬁed and tagged with the FLAG sequence
(DYKDDDDK). The fragment was further cloned into
pX, a Leishmania-speciﬁc expression vector (34), between
two Hsp83 intergenic regions (IRs) that provide RNA
processing signals, generating the pX-LeishIF4G-
3-FLAG vector (primer sequences are provided in
Supplementary Table 1). Leishmania major cells were
transfected as previously described (35) with each of the
vectors described above, and stable cell lines were selected
in the presence of 200mg/ml G-418. For pull-down assays,
transgenic L. major cells (2 10
9) were harvested, washed,
resuspended in CB and lyzed by sonication. For TAP-
tagged protein puriﬁcation, supernatants were agitated
with streptavidin-Sepharose beads (GE Healthcare) for
3h at 48C. The beads were washed with CB containing
0.1% NP-40 and the proteins were eluted with CB supple-
mented with 2mM biotin. For LeishIF4E-1, the eluate
was loaded on IgG-Sepharose beads (GE Healthcare)
and agitated for 3h at 48C. The beads were then washed
with CB containing 0.1% NP-40 and the elution was per-
formed by a short incubation in HAc pH 3.4, which was
neutralized by the addition of saturated Tris buﬀer pH 7.
For LeishIF4E-4 expressing cells, the eluate was loaded on
an m
7GTP-Sepharose column. The column was washed
with CB containing 0.1% NP-40 and once with the same
buﬀer containing 0.1mM GTP. The proteins were eluted
by 0.5M NaCl in CB/0.1% NP-40. The eluted proteins
were precipitated by TCA, fractionated by SDS–PAGE
(12%) and subjected to western blot analysis with speciﬁc
antibodies against the diﬀerent LeishIF4F subunits. For
the FLAG-tagged proteins the supernatant was rotated
with prewashed anti-FLAG-Agarose beads (Sigma) for
3h at 48C. The beads were washed three times with CB
containing 0.1% Triton X-100, and the bound proteins
were analyzed by SDS–PAGE (12%).
Yeast two-hybrid assays
A yeast two-hybrid assay was performed using the com-
mercial GAL4 Two-Hybrid Phagemid Vector Kit
(Stratagene) following the manufacturer’s instructions.
The ORF of LeishIF4E-4 was fused to the GAL4-binding
domain (pBD) whereas the ORF of LeishIF4G-3 was
fused to the GAL4 activation domain (pAD) generating,
respectively, pBD-LeishIF4E-4 and pAD-LeishIF4G-3.
LeishIF4G-3 fragments corresponding to amino acids
1–49, 50–305, 306–635 and mutants of the amino termi-
nal domain (1–49) were generated by PCR (see
Supplementary Table 1 for primer details), using PFU-
Turbo (Stratagene). All constructs were conﬁrmed by
DNA sequencing. The yeast strain YRG-2 (Mata ura352
his3-200 ade2-101 lys2-801 trp1-901 leu2-3 112 gal4-542
gal80-538 LYS2::UASGAL1-TATA GAL1-HIS3
URA3::UASGAL4 17mers(x3) TATACYC1-lacZ) was
cotransformed with pBD-LeishIF4E-4 and pAD-
LeishIF4G-3. Yeast transformants were cultured in
Liquid SD-2 (-Trp/-Leu) medium at 308C overnight,
diluted to a ﬁnal concentration of O.D600=0.15 and con-
tinued growth to O.D600=0.6. Yeast were spotted on
SD-3 (-Trp/-Leu/-His) and SD-2 (-Trp/-Leu) plates, with
or without 2.5mM 3-amino-1,2,4-triazole (3-AT) (Sigma),
respectively. Controls for the yeast two-hybrid assay
are based by pAD-WT and pBD-WT (positive control)
cotransformation, or pAD-WT and pLamin C plasmids
(negative control), following the manufacturer’s
instructions.
Log phase yeast culture (O.D600=10) were harvested,
washed with ddH2O and resuspended in 200ml SDS–
PAGE sample buﬀer. After boiling for 10min, glass
beads were added and the cells were vortexed for 5min.
The glass beads were then discarded and the extracts were
centrifuged at 16000g for 2min. Samples (O.D600=1.0)
were separated by SDS–PAGE (15%) and the gels were
blotted and exposed to speciﬁc antibodies against
LeishIF4E-4. The presence of recombinant pAD-
LeishIF4G-3 fragments in transgenic yeasts was detected
by PCR from yeast colonies (see Supplementary Figure 2)
using primers derived from the pAD plasmid (see
Supplementary Table 1).
LeishIF4E-1 NMR titration experiments with
LeishIF4G-3
NMR spectra were recorded at 298K on a Varian Inova
600-MHz spectrometer equipped with a cryoprobe.
NMR measurements were carried out on samples contain-
ing 250mM
15N-labeled, partially deuterated sample of
LeishIF4E-1 bound to m
7GTP in buﬀer constituted of
50mM Na2HPO4, 50mM NaH2PO4, 0.5mM EDTA,
2mM DTT and 8% D2O at pH 6.5. LeishIF4G-3 peptide
(NYLEPPYPGFSLDEVVRR synthesized at the Tufts
University Core Facility) concentration was gradually
increased in molar ratio ranging from 0.5 to 10 times rel-
ative to LeishIF4E-1 initial concentration. Trosy version
of HSQC spectra (36) were recorded with 172 complex
points in the indirect
15N dimension and 1024 complex
points in the direct dimension.
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LeishIF4G-3 is part of the parasite cap-binding complex
and is purified on an m
7GTP-Sepharose column
A bioinformatics search of the Leishmania and trypano-
some genomes highlighted several proteins that share
structural domains with eIF4G from higher eukaryotes.
To conﬁrm which of the candidates is indeed part of the
translation initiation machinery, functional assays were
pursued. In higher eukaryotes, components of the eIF4F
complex can be eluted from an m
7GTP-Sepharose column
through the ability of eIF4E to interact with the m
7GTP
cap structure. Based on former results showing that spe-
ciﬁc recombinant LeishIF4E isoforms can interact with
m
7GTP, components of the endogenous cap-binding com-
plex were also identiﬁed by aﬃnity puriﬁcation of proteins
from whole cell extracts of L. major over an m
7GTP-
Sepharose column. The parasite cap-binding complexes
were eluted and proteins were separated by SDS–PAGE.
A  70kDa excised band (Supplementary Figure 1A) was
identiﬁed in two independent experiments by mass spec-
trometry as LmjF16.1600, a homolog of eIF4G that was
denoted LeishIF4G-3 (Supplementary Figure 1B). This
ﬁnding supports that LeishIF4G-3 is a potential candidate
to act as a translational initiation factor and is in good
agreement with a former report showing that this protein
can interact with the parasite eIF4A helicase, which is
one of the eIF4F subunits (32). Western blot analysis of
the fractions that were eluted from the m
7GTP-Sepharose
column depicted the presence of LeishIF4E-1 and
LeishIF4E-4, LeishIF4A as well as LeishIF4G-3
(Figure 1). LeishIF4E-2 and LeishIF4E-3 were not
expected to be eluted from the m
7GTP column.
LeishIF4E-2 does not bind eﬃciently to m
7GTP, and
LeishIF4E-3 does not purify well from m
7GTP-
Sepharose, although it was shown to bind m
7GTP using
ﬂuorescence titration assays (31,32). Thus, aprobable form
of the LeishIF4F complex which includes LeishIF4E-1 or
LeishIF4E-4, LeishIF4A-1 and LeishIF4G-3 was puriﬁed
over the m
7GTP-Sepharose column.
LeishIF4G-3 comigrates with LeishIF4E-1 and
LeishIF4E-4 on sucrose gradients
The LeishIF4G-3 ORF is smaller than the mammalian
eIF4G-I and contains 635 compared with 1560 amino
acids, respectively. It includes the middle domain of
eIF4G (MIF4G), which is highly conserved among diver-
gent organisms (see Supplementary Figure 2), but the
other regions of LeishIF4G-3 bear no signiﬁcant sequence
similarity to the human eIF4GI, with a rather short
N-terminus. In higher eukaryotes, eIF4G was shown to
be mostly distributed in the cytoplasm (37), this was ver-
iﬁed in Leishmania as well (data not shown). To investi-
gate whether LeishIF4G-3 comigrates with LeishIF4E-1
and LeishIF4E-4 in particles of the same size, cell extracts
of L. major cells that were grown at 268C, a temperature
used for growth of Leishmania promastigotes, were frac-
tionated over sucrose gradients. The polysome proﬁle was
monitored by RNA absorbance at 260nm (Figure 2A) and
migration of the ribosomal small subunit was monitored
by western analysis using antibodies directed against
rpS6. Migration of the diﬀerent LeishIF4F subunits
were also monitored by western analysis. As shown in
Figure 2B, LeishIF4G-3 comigrates with LeishIF4E-1
and LeishIF4E-4 in fractions that contain free RNPs at
the top of the gradient (up to fraction 10), as well as in
heavier fractions (10–14) that contain the 40S subunits, as
demonstrated by their reaction with anti-rpS6 antibodies.
In addition, for each of the proteins examined, a weaker
reaction was observed in fractions that correspond to the
80S particles (fractions 23–25). However, this fraction
highlighted lower bands of LeishIF4E-4 and LeishIF4G-
3 as well as a higher band of LeishIF4E-1. Given that the
antibodies against LeishIF4E-1 and LeishIF4E-4 do not
cross-react with the other eIF4E paralogs in Leishmania,
these bands may represent diﬀerent modiﬁcation forms of
the protein, possibly caused by phosphorylation. A very
weak association of LeishIF4E-1 and LeishIF4E-4 with
polysomes was observed (fractions 27–35).
Exposure of the parasites to elevated temperatures,
which mimic the conditions in the human host (1), was
shown to decrease the amount of polysomes in the cell,
and as a result to increase the 80S fraction [(38) and
Figure 2C]. This was reﬂected by the migration proﬁle
of rpS6. While during heat shock LeishIF4E-4 migrates
only as RNPs, LeishIF4E-1 and LeishIF4G-3 maintain
their migration proﬁle with particles that contain the
40S small ribosomal subunit, including the 80S complex.
It therefore appears that LeishIF4E-1 and LeishIF4G-3
most probably function at both life stages.
LeishIF4G-3 interacts with LeishIF4E-1 and
LeishIF4E-4 in vitro
A common feature of the cap-binding complex in eukary-
otes is the interaction between eIF4E and eIF4G.
Copuriﬁcation over m
7GTP-Sepharose column and
Figure 1. Leishmania major cap-binding complex puriﬁcation.
Leishmania major cells were lyzed and the soluble protein extract (S)
was loaded over an m
7GTP-Sepharose column. After collection of the
ﬂowthrough (FT) the column was washed (W) with CB (see Materials
and Methods section) and with CB containing 100mM GTP (GTP).
The proteins were eluted (E) with CB containing 500mM NaCl.
Equal samples from the diﬀerent fractions were separated by SDS–
PAGE and analyzed by western blot using speciﬁc antibodies against
the diﬀerent subunits of the Leishmania cap-binding complex
(LeishIF4E-1 through LeishIF4E-4, LeishIF4G-3, LeishIF4A-1).
Similar results were obtained when the m
7GTP-Sepharose column
was eluted with free m
7GTP.
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ity of the parasite proteins to physically interact, although
being indirect. Therefore, pull-down assays using a GST-
LeishIF4G-3 fusion protein, or GST alone were expressed
in bacteria and immobilized onto Glutathione-Agarose
beads. These beads were incubated with the soluble
extracts of bacteria, each expressing one of the four
LeishIF4Es, or the mouse eIF4E ortholog. The complexes
were eluted and their components were identiﬁed by west-
ern blot analysis using speciﬁc antibodies. As shown in
Figure 3, LeishIF4G-3 pulled-down LeishIF4E-1 and
LeishIF4E-4, but not LeishIF4E-2 or LeishIF4E-3, when
compared with the GST control. No interaction was
observed between LeishIF4G-3 and the mouse eIF4E,
supporting the observed divergence between LeishIF4G-
3 and its mammalian ortholog.
LeishIF4G-3 interacts with LeishIF4E-1 and
LeishIF4E-4 in vivo
The ability of LeishIF4G-3 to interact with the diﬀerent
LeishIF4Es in vivo was investigated in transgenic L. major
cell lines expressing a FLAG-tagged LeishIF4G-3. Cell
extracts were incubated with anti-FLAG-Sepharose
beads and the eluted fractions were analyzed with speciﬁc
antibodies raised against the diﬀerent LeishIF4F subunits.
This analysis conﬁrmed that LeishIF4G-3 could pull-
down LeishIF4E-4, along with LeishIF4A-1 (Figure 4),
and a very weak interaction between the tagged
LeishIF4G-3 and LeishIF4E-1 was also detected.
In view of the diﬀerent results obtained in the in vitro
and in vivo tagging experiments that examine the interac-
tion between LeishIF4G-3 and LeishIF4E-1, a reciprocal
in vivo tagging approach was used. LeishIF4E-1 and
LeishIF4E-4 were fused to the tandem aﬃnity puriﬁcation
(TAP)-tag, using the pPNSAP1 vector (33), which adds
Figure 2. LeishIF4G-3 comigrates with LeishIF4E-1 and LeishIF4E-4 by
sucrose gradients analysis. Extracts of L. major cells grown at 268C, and
after exposure to 358C for 18h were loaded on 10–50% sucrose gradients.
(A) Pattern of polysome migration on sucrose gradients. Fractions were
collected from the top of the gradient and the O.D260nm was monitored.
(268C, continuous line; 358C, broken line). Proteins were recovered
by TCA precipitation, and immunoblotted with antibodies raised against
LeishIF4E-1, LeishIF4E-4, LeishIF4G-3 as well as with anti-rpS6,
for detection of fractions that contain complexes containing 40S
particles. Western analysis was done on fractions of cells that were
grown at 268C( B) and 358C( C).
Figure 3. LeishIF4G-3 interacts with LeishIF4E-1 and LeishIF4E-4
in vitro. GST or GST-LeishIF4G-3 fusion protein were immobilized
on Glutathione-Agarose beads. The beads were incubated with super-
natant of bacteria that express the diﬀerent LeishIF4E isoforms or the
mouse eIF4E ortholog (S). After extensive washes (W) the protein
complexes were eluted (E), and analyzed by western blot with speciﬁc
antibodies against the diﬀerent eIF4Es.
Figure 4. LeishIF4G-3-FLAG pulls down LeishIF4E-4. Leishmania
major cells were transfected with pX-LeishIF4G-3-FLAG and cell
lines expressing the FLAG tagged LeishIF4G-3 were selected in the
presence of 200mg/ml G418. The cells were lyzed by sonication and
the soluble fractions (S) were incubated with anti-FLAG beads. After
incubation for 3h, the beads were washed (W), the proteins were eluted
(E), separated by SDS–PAGE and analyzed by western blot.
Nucleic Acids Research, 2009,Vol.37, No. 10 3247two diﬀerent in frame tags, a Protein A peptide and a
streptavidin-binding peptide. The tagged LeishIF4E-1
was ﬁrst bound to streptavidin beads, and the biotin-
eluted fractions were further subjected to puriﬁcation on
an IgG-Sepharose column (Figure 5A). For the tagged
LeishIF4E-4, the second round of puriﬁcation was per-
formed over m
7GTP-Sepharose, taking advantage of the
cap-binding activity of LeishIF4E-4 (Figure 5B). Western
blot analysis of the puriﬁed complexes conﬁrmed that
LeishIF4G-3 was coprecipitated with LeishIF4E-1 and
LeishIF4E-4. The pull-down of LeishIF4G-3 by the
tagged LeishIF4E-1 was more eﬃcient than the reciprocal
pull-down of LeishIF4E-1 by tagged LeishIF4G-3, possi-
bly due to over expression of the tagged LeishIF4E-1 in
the transgenic parasites, which could serve to enhance a
basically weaker interaction. The two TAP-tagged cap-
binding complexes also contained LeishIF4A-1, the third
components of the eIF4F complex.
The interaction between LeishIF4G-3 and LeishIF4E-4
is mediated through a short peptide in its N-terminus
The GAL4 yeast two-hybrid system provides an alterna-
tive approach to monitor the interactions between
LeishIF4G-3 and LeishIF4Es. This assay was used to
map the LeishIF4G-3 fragment that is responsible for
binding to LeishIF4E-4. LeishIF4E-4 was fused to the
binding domain (BD) of GAL4 whereas LeishIF4G-3, or
derivative fragments were fused to the GAL4 transcription
activation domain (AD). The interaction between the
tested proteins brings together the GAL4 DNA binding
and transcriptional activation domains, resulting
in transcription of the HIS3 gene, and growth of the
cotransformed yeast cells on selective medium lacking
histidine. The LeishIF4G-3 fragments that were investi-
gated corresponded to the ﬁrst 49 amino acids in the
N-terminus (LeishIF4G-31-49), the MIF4G domain that
comprises amino acids 50–305 (LeishIF4G-350–305) and
the C-terminal domain that lies between amino acids
306–635 (LeishIF4G-3306–635) (Figure 6A). Growth in
the absence of histidine was promoted only in yeast
cells expressing either the full-length LeishIF4G-3 or its
N-terminal domain, LeishIF4G-31–49, indicating that the
amino terminus is indeed responsible for the interaction
with LeishIF4E-4. The presence of the foreign genes
(LeishIF4E-4 andthe LeishIF4G-3 fragments) in the trans-
genic yeast was veriﬁed (see Supplementary Figure 3).
While cells expressing the C-terminus LeishIF4G-3305–635
did not grow on medium-lacking histidine, the MIF4G
domain of LeishIF4G-3 (LeishIF4G-350–305), showed a
very weak interaction with LeishIF4E-4, which caused
a feeble growth of yeast on the selective medium
(Figure 6B).
In higher eukaryotes the interaction of eIF4G with
eIF4E is based on a short sequence motif Y(X4)L,
where X corresponds to any amino acid and  is a hydro-
phobic residue (27,28). A similar sequence element was
found in the N-terminus of LeishIF4G-3 between posi-
tions 20 and 26 (YPGFSLD, Figure 7A). The peptide
contains the consensus element 20-Y(X4)L-25, however,
the conserved hydrophobic residue is replaced with an
acidic amino acid, aspartic acid in Leishmania and gluta-
mic acid in trypanosomes. Mutations were introduced in
speciﬁc amino acids in the LeishIF4G-3 peptide, and their
eﬀect on binding to LeishIF4E-4 was examined using the
yeast two-hybrid system (Figure 7B). The mutations were
introduced into the N-terminal fragment of LeishIF4G-3
(amino acids 1–49) to avoid the masking of any negative
binding by the presence of the MIF4G domain, which
showed residual binding. Mutating the tyrosine at position
20 to alanine, but not to phenylalanine, eliminated the
binding of LeishIF4G-31–49 to LeishIF4E-4. Similarly,
the conserved leucine at position 25 is essential for bind-
ing, as expected. Unlike higher eukaryotes, where muta-
tions in the amino acids that follow the tyrosine do not
aﬀect binding to eIF4E (27), in LeishIF4G-3 orthologs of
trypanosomatids, these amino acids (21-PGFS-24) are
conserved and some are also essential for binding.
Replacement of phenylalanine 23 to alanine completely
abrogates binding to LeishIF4E-4. Other mutations also
aﬀect yeast growth, though to a partial level: the exchange
of glycine 22 with an alanine slowed down yeast growth
rather eﬃciently whereas mutation of proline 21 had a
much milder eﬀect. In the ﬂanking region, the only muta-
tion that decreased binding to LeishIF4E-4 was the
Figure 5. LeishIF4G-3 and LeishIF4A-1 copuriﬁy with TAP-tagged LeishIF4E-1 and LeishIF4E-4. Leishmania major wild-type or transgenic cells
expressing TAP-tagged LeishIF4E-1 (A) and LeishIF4E-4 (B) were lyzed and the soluble supernatant (S) was loaded on streptavidin-Sepharose
beads. The beads were washed, eluted with biotin and repuriﬁed in tandem over IgG-Sepharose beads (LeishIF4E-1) or over m
7GTP-Sepharose
beads (LeishIF4E-4). The corresponding beads were washed (W) and eluted (E, see Materials and Methods section). The W and E lanes were loaded
with 20% of the wash and eluate volumes, respectively. All proteins were fractionated by SDS–PAGE (12%) and subjected to western blot analysis
using antibodies speciﬁc against LeishIF4E-1, LeishIF4E-4, LeishIF4G-3 and LeishIF4A-1.
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whereas exchange of aspartic acid 26 with alanine had
no such eﬀect. The valine residues at positions 28 and 29
are not conserved among trypanosomatids, suggesting
that they are not required for the direct binding. Indeed,
valine 29 is dispensable for yeast growth, as shown by its
exchange to phenylalanine.
The binding to LeishIF4E-1 of a synthetic short peptide
of 18 amino acids (14-NYLEPPYPGFSLDEVVRR-31)
from the LeishIF4G-3 sequence, encompassing the con-
sensus eIF4E-binding motif, was also investigated by
NMR titration. LeishIF4E-1 was used for technical rea-
sons, since the recombinant protein is more soluble than
LeishIF4E-4 and stable at 258C for a prolonged period.
Further, LeishIF4E-1 binds m
7GTP with an aﬃnity sim-
ilar to cap-4 (30). m
7GTP was added to LeishIF4E-1 prior
to recording the NMR spectra in order to stabilize
the protein. A [
15N,
1H]TROSY-HSQC spectrum (36)
was recorded using uniformly
15N-labeled LeishIF4E-1
(LeishIF4E-1 free) (Figure 8A). In subsequent experi-
ments, unlabeled LeishIF4G-3 peptide was added in
increasing molar ratios. This resulted in chemical shift
changes in a select subset of resonances (Figure 8B and
C) indicating that LeishIF4G-3 peptide binds to
LeishIF4E-1.
DISCUSSION
The cap-binding complex in Leishmania and trypanoso-
matids is of special interest in view of the unusual cap-4
structure, which is found at the 50-end of all mRNAs.
Figure 6. Monitoring the LeishIF4G-3 interaction with LeishIF4E-4 by the yeast two-hybrid assay. (A) Scheme of LeishIF4G-3 highlighting the
location of its eIF4E-binding region and the MIF4G domain, as compared with the human eIF4GI. (B) Yeast cells were cotransformed with pBD-
LeishIF4E-4 and pAD fused to diﬀerent fragments of LeishIF4G-3 as indicated (1–49, 50–305, 306–635), or with positive or negative control
plasmids (see Material and Methods section for details). The cells were cultured in Liquid SD-2 (-Trp/-Leu/+His), and 3-fold dilutions were spotted
on SD-2 or SD-3 (-Trp/-Leu/-His) containing 2mM 3-AT; the plates were incubated at 308C for 10 days.
Figure 7. Eﬀect of mutations in the LeishIF4G-3 consensus peptide on
binding to LeishIF4E-4. (A) Sequence conservation of the consensus
peptide [Y(X4)L] of LeishIF4G-3 in diﬀerent trypanosomatids
(L. major, L. infantum, T. cruzi, T. brucei), as compared with the
human peptide (H. sapiens). (B) Yeast cells were cotransformed with
pBD-LeishIF4E-4 and pAD fused to the LeishIF4G-31–49 fragment
carrying diﬀerent point mutations in the consensus peptide. The cells
were cultured as described in the legend of Figure 6, and growth in the
absence of histidine served as an indication for binding between
LeishIF4G-3 and LeishIF4E-4.
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LeishIF4E, must have gone through changes that enable
eﬃcient binding to, and assembly on this highly modiﬁed
structure. This is reﬂected by the inability of the diﬀerent
LeishIF4Es to replace eIF4E from higher eukaryotes (31).
A bioinformatics analysis highlighted the presence of sev-
eral putative eIF4G homologs in Leishmania; in this study,
we showed that one of these candidates, LeishIF4G-3 was
eluted from an m
7GTP-Sepharose column, along with
LeishIF4E-1, LeishIF4E-4 and LeishIF4A-1, which are
part of the eIF4F complex. This strongly suggests that
LeishIF4G-3 is the general translation factor of trypano-
somatids. However, proteins which were eluted from an
m
7GTP column are not restricted to translation, and
could be associated with other RNA metabolism and
transport processes between the nucleus and the cyto-
plasm. Thus, a more direct approach for monitoring the
interactions between the putative LeishIF4G-3 and
the Leishmania cap-binding translation initiation factors
is required. We therefore characterized the interaction
between LeishIF4G-3 and the diﬀerent LeishIF4E
homologs by pull-down assays. Only LeishIF4E-1 and
LeishIF4E-4 were coprecipitated in vitro with the
recombinant GST-LeishIF4G-3 fusion protein from
Glutathione-Agarose beads, in agreement with our pre-
vious report on their ability to bind the human 4E-BP1.
LeishIF4G-3 comigrates with LeishIF4E-1 and
LeishIF4E-4 in sucrose gradients, supporting that these
proteins can share the same sub-cellular particles.
The eﬀect of heat shock on the migration proﬁle of
polysomes in Leishmania is in agreement with other
reports in Trypanosoma brucei, showing that the relative
amount of polysomes decreases whereas the 80S fraction is
enlarged (38). In response to temperature elevation of
Leishmania parasites, LeishIF4E-4 disintegrates from
heavier complexes, and is found only at the top of the
gradient, as free RNPs. However, LeishIF4E-1 which
goes up in amastigotes (31), and LeishIF4G-3 continues
to comigrate with the 80S particles, even when the general
translation activity is low. This is in-line with the require-
ment that amastigotes resume their protein synthesis activ-
ity at elevated temperatures following diﬀerentiation to
the life form that resides in mammals.
The interactions between recombinant proteins in vitro
do not always provide a faithful reﬂection of the parallel
in vivo processes, because they do not involve the complete
subunit repertoire of their complexes. The interaction
between LeishIF4G-3 and LeishIF4Es were therefore
monitored in vivo. FLAG-tagged LeishIF4G-3 was able
to pull-down only LeishIF4E-4. However, the reciprocal
approach, where both LeishIF4E-1 and LeishIF4E-4
were TAP-tagged in vivo, veriﬁed the interaction between
Figure 8. Binding of a LeishIF4G-3 peptide to LeishIF4E-1. (A)
15N,
1HTROSY-HSQC spectra of
15N-labeled LeishIF4E-1 (250mM) in the presence
of m
7GTP (5mM) for stabilization (LeishIF4E-1 free, in blue). (B) Overlays of
15N,
1HTROSY-HSQC spectra of
15N-LeishIF4E-1 free with
increasing amounts of non-labeled LeishIF4G-3 peptide (NYLEPPYPGFSLDEVVRR). The concentrations of the LeishIF4G-3 added were 0mM
(blue, ratio 1:0), 250mM (red, ratio 1:1) and 1.25mM (green, ratio 1:5). (C) Enlargement of a region displaying the chemical shift diﬀerences between
the spectra that is boxed in (B) in dashed lines. Peaks movements are indicated by arrows.
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4, in agreement with the results obtained from the in vitro
pull-down assays. In the case of TAP-tagged LeishIF4E-1,
the anti-LeishIF4G-3 antibodies identiﬁed a band
that migrates slightly faster, suggesting perhaps that
LeishIF4E-1 and LeishIF4E-4 interact with diﬀerent
phosphorylated forms of LeishIF4G-3 (Figure 5). This
faster migrating band also cosediments with LeishIF4E-1
and LeishIF4E-4 in sucrose gradients (Figure 2).
In yeast eIF4G, the amino terminus is unfolded, and
binding to eIF4E induces the folding of a region that
encompasses 100 amino acids (positions 393–490) into a
‘molecular bracelet’ of a-helices that encircles the unstruc-
tured amino terminus of the eIF4E (18,39). In LeishIF4G-
3 the amino terminus is much shorter, and consists of
only 49 amino acids upstream of the ﬁrst HEAT repeat.
This region was found to be suﬃcient to promote the
binding of LeishIF4G-3 to LeishIF4E-4, as indicated by
the yeast two-hybrid assay.
An oligo-peptide in the N-terminal region of
LeishIF4G-3 that shows partial conservation with the
consensus signature peptide Y(X4)L of higher eukaryotes
was veriﬁed by speciﬁc point mutations (Figure 7). The
ﬁrst tyrosine of the LeishIF4G-3 peptide is essential for
binding to LeishIF4E-4. Its replacement by alanine abro-
gates the binding completely, whereas replacement by a
phenylalanine residue indicates that the peptide is still
functional, although growth of the yeast expressing the
Y20F mutant is slower. A similar exchange in the
human eIF4G peptide where tyrosine was replaced by
phenylalanine had little, or no eﬀect on its binding to
eIF4E (27). Both amino acids are aromatic and a pheny-
lalanine residue also occupies the parallel position in
the consensus peptide of eIF4G from C. elegans
(386-FGRDFMV-392). As expected, the leucine residue
(L25) in the peptide is conserved and essential, and its
replacement by alanine eliminates binding to LeishIF4E-
4 completely. However, the subsequent residue in trypa-
nosomatids is not hydrophobic, as in higher eukaryotes,
and is replaced by an acidic residue, aspartic acid in
L. major and L. infantum, or glutamic acid in T. brucei
and T. cruzi (Figure 7A). This acidic residue is nonessen-
tial in Leishmania, and can be replaced by alanine without
aﬀecting the binding between LeishIF4G-3 and
LeishIF4E-4. Another example where the hydrophobic
residue is not conserved is the eIF4E-binding peptide
(YERAFMK) of 4E-BP from Drosophila melanogaster
(NP_477295), where the sixth position following the tyr-
osine in that peptide is occupied by a basic lysine residue,
marked in bold. In contrast, the neighboring glutamic acid
at position 27 from LeishIF4G-3 participates in the bind-
ing activity to LeishIF4E. We further highlighted addi-
tional deviations of the LeishIF4G-3 signature peptide
as compared with its higher eukaryotic counterpart. The
four amino acids that follow the essential tyrosine residue
(Y20) are conserved among trypanosomatids, and our
mutational analysis shows that the phenylalanine (F23)
is essential, whereas the proline and glycine residues
(P21 and G22) have a partial eﬀect on the binding. In
higher eukaryotes, replacement of amino acids at these
positions has no eﬀect on the binding to eIF4E (27).
The diﬀerent structural requirements in the peptide of
LeishIF4G-3 are most probably required to promote
assembly of the parasite eIF4F subunits on the highly
modiﬁed cap-4 structure. The binding of the LeishIF4G-
3 peptide to LeishIF4E-1 was also investigated by NMR
spectroscopy. Following the addition of an 18 amino acids
LeishIF4G-3 peptide to LeishIF4E-1, chemical shifts were
observed, when compared with the LeishIF4E-1 NMR
spectra recorded in the absence of the same peptide
(Figure 8). The resonances that were most strongly
aﬀected mapped to amino acids in LeishIF4E-1 that are
homologous (by sequence alignment) to the binding site in
the mouse and yeast eIF4Es.
The deviations of the cap-4 binding complex of
Leishmania from its higher eukaryote counterpart are fur-
ther emphasized by the inability of LeishIF4G-3 to bind
the murine eIF4E (Figure 3). This can be partly due to
changes in the eIF4E binding peptide that are described
above, and to the fact that the amino terminus of
LeishIF4G-3 is rather short, questioning its ability to
create the ‘molecular bracelet’ that has been shown for
the yeast eIF4G. In higher eukaryotes, the amino terminus
is also responsible for interacting with the PABP at the
30-end of the mRNA. This is in agreement with our inabil-
ity to show direct binding of LeishIF4G-3 to the
Leishmania PABP (40) in the yeast two-hybrid assay
(data not shown). At this stage we cannot exclude the
possibility that the translation initiation complex in
Leishmania may contain additional components that com-
plement the function of the LeishIF4G-3 amino terminus
in stabilizing the LeishIF4F complex.
Unlike most eIF4E homologs from higher eukaryotes,
LeishIF4E-4 has a relatively long amino terminus of
about 100 amino acids, and overall shows a low degree
of conservation with eIF4E from higher eukaryotes.
Furthermore, part of the residues that occupy positions
which are expected to interact with eIF4G are not con-
served (31). This includes exchange of the murine histidine
37 and proline 38 by methionine residues at both positions
in LeishIF4E-4.
In conclusion, the variability in the amino termini of
LeishIF4G-3 and LeishIF4E-4, as well as the speciﬁc
changes of conserved amino acids that are expected to
promote the interaction between them, could represent
adaptations that occurred during evolution to enable the
eIF4F assembly on the unique cap-4 moiety in trypanoso-
matids. In view of the above, we further speculate that
the cap-4 binding complex could possibly serve as an intri-
guing target for the development of novel drugs, as shown
for eukaryotes, where inhibitors of the interaction between
eIF4E and eIF4G aﬀect the growth of malignant cells in
culture (41).
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